Status:
COMPLETED
Prospective, Monocentric, Interventional Study on Spontaneous Vaginal Clearance of Mycoplasma Genitalium
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Mycoplasma Genitalium Infection
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
It is a prospective, monocentric, interventional study on spontaneous vaginal clearance of Mycoplasma genitalium. The main objective is to evaluate the spontaneous vaginal clearance of M. genitalium ...
Detailed Description
Mycoplasma genitalium is a bacterium that colonizes female genital tract and can be responsible for sexually transmitted infection . M. genitalium can cause cervicitis and more rarely high genital inf...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient selected during the first consultation, pre-abortion, and having a vaginal swab positive to M. genitalium.
- Patient hospitalized for an abortion at the University Hospital of Bordeaux.
- An affiliated patient or beneficiary of a social security system.
- Signing free and informed consent.
- Exclusion criteria:
- Patient with vaginal co-infection with C. trachomatis.
- Patient with symptoms of high genital infection.
- Taking fluoroquinolones, macrolides or tetracyclines within 21 days of inclusion.
- Patient under legal protection.
Exclusion
Key Trial Info
Start Date :
April 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 21 2023
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT04841408
Start Date
April 5 2021
End Date
February 21 2023
Last Update
April 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Bordeaux
Bordeaux, France